- Companies
- PhaBuilder
PhaBuilder Valuation, Funding & Investors
PhaBuilder is valued at $287M as of February 2023.
Last PhaBuilder valuation
$287M
Series A · Feb 2023
Last PhaBuilder funding round
$52M
Series A · Feb 2023
Cumulative funding PhaBuilder raised
$112M
across 4 funding rounds
Key investors in PhaBuilder
HSG
Z&H Investment
GRC SinoGreen Fund
Sino Biological
Shenzhen Guozhong Venture Capital Management
FTZ Fund
About PhaBuilder
PhaBuilder is a synthetic biology firm engineering halophilic microbes for industrial applications through next-generation biotechnology. It produces biodegradable PHA polymers, ectoine as a pharmaceutical intermediate, and cadaverine for Nylon 56 precursors. Based in Beijing at the China-Germany Industrial Park, PhaBuilder develops products in its synthetic biology facility and constructs a PHA production plant in Yichang, Hubei Province. The company expands with additional large-scale bases across China.
Founded
2021
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Valuation
$287M (Feb 2023)
PhaBuilder Valuation
PhaBuilder is currently valued at $287M, based on its Series A in February 2023. Read the announcement ↗
The $52M round was led by China National Petroleum Group Kunlun Capital, with participation from FTZ Fund, Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership), Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership), Enterprise Mixed Ownership Reform Fund, Lhasa Alec Investment Consulting and 6 other investors.
PhaBuilder valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Feb 2023 | Series A | $287M |
PhaBuilder Funding History
PhaBuilder has raised a total of $112M across 4 funding rounds.
PhaBuilder's first fundraising round was a $8M angel round in July 2021. The most recent completed round was a $52M Series A in February 2023.
PhaBuilder funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Feb 2023 | Series A | China National Petroleum Group Kunlun Capital (lead); FTZ Fund; Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership); Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership); Enterprise Mixed Ownership Reform Fund; Lhasa Alec Investment Consulting; Mingqu Capital; Sino Biological; GRC SinoGreen Fund; Agricultural Fund of China; Z&H Investment; HSG | $52M | $287M | - |
| Nov 2022 | Series A | Sino Biological (lead) | $13M | - | - |
| Jan 2022 | Series A | Chengtong Mixed Reform (lead); Huakong Electronic Technology; Shenzhen Guozhong Venture Capital Management; Beijing Linkong Xingrong Investment; GRC SinoGreen Fund; Z&H Investment; HSG | $39M | - | - |
| Jul 2021 | Angel | HSG (lead); SEE Fund; Ningbo Qiwu Management Consulting Partnership | $8M | - | Beijing PhaBuilder Biotechnology Co., Ltd. develops synthetic biology technologies to produce PHA (Polyhydroxyalkanoates), a family of biodegradable polymers including PHB, PHBV, and P34HB, for applications in medical, fashion, 3D printing, packaging, and consumer goods. The company engineers halophilic microorganisms using non-grain carbon sources like straw and kitchen waste, integrating Industry 4.0 principles for high-efficiency, low-carbon biomanufacturing. PhaBuilder promotes a 'PHA Life' concept to create green, low-carbon lifestyles by replacing traditional plastics with biodegradable PHA products. Founded in 2021, it originated from Tsinghua University technology by Professor George Guo-Qiang Chen. |
Who has invested in PhaBuilder?
18 investors have backed PhaBuilder across its funding rounds, including HSG, Z&H Investment, GRC SinoGreen Fund, Sino Biological, Shenzhen Guozhong Venture Capital Management and FTZ Fund.
Lead investors include China National Petroleum Group Kunlun Capital, Sino Biological, Chengtong Mixed Reform and HSG.
PhaBuilder Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Jul 2021 | ||
| 2 | Lead | Nov 2022 | ||
| 2 | Participant | Jan 2022 | ||
| 2 | Participant | Jan 2022 | ||
| 1 | Participant | Jan 2022 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Lead | Jan 2022 | ||
| 1 | Participant | Jul 2021 | ||
| 1 | Participant | Jan 2022 | ||
| 1 | Participant | Jul 2021 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Participant | Feb 2023 | ||
This data is available for Pro users. Sign up to see all 18 PhaBuilder investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialPhaBuilder Competitors
PhaBuilder competitors include listed companies like eVISO and Alfa Solar, and private ones like BioElements, Toraphene, TemperPack and Hydrosat.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $6M | - | $200M | 33.3x | ||
| Private | $1M | - | $111M | 110.5x | ||
| Private | - | - | $108M | - | ||
| Private | - | - | $180M | - | ||
| Publicly listed | $363M | $12M | $277M | 0.6x | ||
| Publicly listed | $169M | $10M | $256M | - |
PhaBuilder Public Comps
PhaBuilder is still privately-owned, but its public comps include eVISO, Transcontinental, Alfa Solar, Smart Gunes Enerjisi Tek, Nampak, Itafos, Tredegar, Clearwater Paper, Envipco Holding and Ranpak.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $363M | $12M | 0.7x | 0.6x | 22.8x | 16.6x | |||
| $2B | $340M | 0.3x | 0.6x | 1.8x | 3.6x | |||
| $169M | $10M | 1.7x | - | 30.6x | - | |||
| $217M | $49M | 2.3x | - | 10.3x | - | |||
| $660M | $136M | 0.7x | 0.7x | 3.3x | 4.8x | |||
| $558M | $189M | 0.7x | 0.6x | 1.9x | 3.4x | |||
| $723M | $56M | 0.4x | - | 5.0x | - | |||
| $1.6B | $47M | 0.4x | 0.4x | 13.1x | 10.4x | |||
This data is available for Pro users. Sign up to see all PhaBuilder competitors and their valuation data. Start Free Trial | ||||||||
Common questions about PhaBuilder
| When was PhaBuilder founded? | PhaBuilder was founded in 2021. |
| Where is PhaBuilder headquartered? | PhaBuilder is headquartered in Beijing, China. |
| Is PhaBuilder publicly listed? | No, PhaBuilder is a private, VC-backed company. |
| What is PhaBuilder's valuation? | PhaBuilder was last valued at $287M in its Series A in February 2023. |
| How much funding has PhaBuilder raised? | PhaBuilder has raised $112M across 4 funding rounds. |
| What was PhaBuilder's last funding round? | PhaBuilder's last funding round was a $52M Series A in February 2023, led by China National Petroleum Group Kunlun Capital. |
| Who are PhaBuilder's investors? | PhaBuilder's investors include HSG, Sino Biological, GRC SinoGreen Fund, Z&H Investment, Huakong Electronic Technology, FTZ Fund, Chengtong Mixed Reform, SEE Fund, Shenzhen Guozhong Venture Capital Management, Ningbo Qiwu Management Consulting Partnership and 8 others. |
| Which companies are comparable to PhaBuilder? | Companies comparable to PhaBuilder include BioElements, Toraphene, TemperPack, Hydrosat, eVISO and Alfa Solar. |
See companies similar to PhaBuilder
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




